Improving the Endoscopic Detection Rate in Patients with Early Gastric Cancer

Hee Seok Moon

doi:10.5946/ce.2015.48.4.291

Articles

Page Path: HOME > Clin Endosc > Volume 48(4); 2015 > Article

Review Improving the Endoscopic Detection Rate in Patients with Early Gastric Cancer: Hee Seok Moon; Clinical Endoscopy 2015;48(4):291-296.
DOI: https://doi.org/10.5946/ce.2015.48.4.291
Published online: July 24, 2015

Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.

Correspondence: Hee Seok Moon. Department of Internal Medicine, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea. Tel: +82-42-280-7163, Fax: +82-42-280-7142, mhs1357@cnuh.co.kr

• Received: April 20, 2015 • Revised: May 22, 2015 • Accepted: June 2, 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

18,495 Views
393 Download
16 Web of Science
17 Crossref
19 Scopus

prev next

Full Article

Download PDF

Abstract
INTRODUCTION
HIGH-RISK GASTRIC CANCER GROUPS
ENDOSCOPIC EXAMINATION WITHOUT BLIND SPOTS
ENDOSCOPIC FINDINGS OF EGC
CHROMOENDOSCOPIC EXAMINATION
CONCLUSIONS
NOTES
REFERENCES

Abstract

Endoscopists should ideally possess both sufficient knowledge of the endoscopic gastrointestinal disease findings and an appropriate attitude. Before performing endoscopy, the endoscopist must identify several risk factors of gastric cancer, including the patient's age, comorbidities, and drug history, a family history of gastric cancer, previous endoscopic findings of atrophic gastritis or intestinal metaplasia, and a history of previous endoscopic treatments. During endoscopic examination, the macroscopic appearance is very important for the diagnosis of early gastric cancer; therefore, the endoscopist should have a consistent and organized endoscope processing technique and the ability to comprehensively investigate the entire stomach, even blind spots.
Keywords: Endoscopy; Early gastric cancer; Detection

INTRODUCTION

Gastric cancer is the second most common cancer and the third leading cause of cancer-related death in Korea.1 Recent advances in endoscopic technology and heightened interest in public health have led to rapid developments in endoscopic screening tests. Patients with early gastric cancer (EGC) have excellent prognoses and 5-year survival rates exceeding 90%. Furthermore, endoscopic submucosal dissection has become a common treatment modality for EGC without lymph node metastasis. Gastrointestinal endoscopy is a very good medical technique for screening and treatment. The endoscopy-related diagnostic rate of EGC recently reached 80%, and the mortality rate of gastric cancer is gradually decreasing.2 3 Thus, endoscopy and biopsy are primarily recommended as tests for the diagnosis of gastric cancer.

However, since some EGCs are only diagnosed on the basis of very delicate changes in the mucosa, extremely careful observation and close biopsy examination are required. In a recent cohort study in England, 2,727 retrospectively tested patients with gastric cancer had an endoscopy miss rate of approximately 8.3%. This miss rate was especially high in patients <55 years (p=0.03) and in female patients (p=0.01).4 In a study by Lee et al.,5 of the 109 lesions in 51 patients with gastric cancer who had undergone gastrectomy and were diagnosed with synchronous multifocal gastric carcinoma, 16 lesions (14.6%) were missed on presurgical endoscopy.

Interval gastric cancer is defined as gastric cancer diagnosed within 2 years after negative endoscopy findings. Cho et al.6 recently analyzed 284 patients with gastric cancer and found that 52 (18.2%) had interval gastric cancer. In this study, the average interval between endoscopy and a cancer diagnosis was 12.6 months, while the average EGC lesion size was 1.3 cm. In addition, many cases were accompanied by intestinal metaplasia. Therefore, it should be considered that many EGC lesions can be missed on endoscopy. This study aimed to improve the early detection of gastric cancer by reviewing previous research. To this end, we investigated some of the principles of preparation for endoscopy and attitudes about the procedure, and discussed the endoscopic findings of EGC.

HIGH-RISK GASTRIC CANCER GROUPS

Gastric cancers are caused by a combination of various factors, including genetic traits, environmental factors, and Helicobacter pylori infection. More specifically, the incidence of gastric cancer increases two to three times in people with a family history of the disease.7 In addition, many studies have reported H. pylori as an important factor causing gastric adenocarcinoma. H. pylori causes chronic gastritis of the gastric mucosa and subsequent atrophic gastritis, intestinal metaplasia, and dysplasia, which finally leads to adenocarcinoma. According to Vannella et al.,8 atrophic gastritis associated with H. pylori causes gastric cancer in 0.6% to 1.1% of cases. Furthermore, the degree of atrophic gastritis, the existence of intestinal metaplasia, and age are the risk factors of the transformation of atrophic gastritis into gastric cancer. One cohort study presented in the Netherlands reported annual incidence rates of gastric cancer of 0.1% from atrophic gastritis, 0.25% from intestinal metaplasia, 0.6% from low-grade dysplasia, and 6% from high-grade dysplasia.9

According to a study by Bang and Kim10 people are at a particularly high risk of gastric cancer if intestinal metaplasia invades 20% or more of the gastric mucosa, histologically incomplete intestinal metaplasia is present, or they smoke or have a family history of gastric cancer. Therefore, people who have atrophic gastritis and intestinal metaplasia should undergo periodic check-ups and should be followed closely. In particular, it is very difficult to make a diagnosis of EGC if a patient has severe intestinal metaplasia; therefore, close observation is also required in such cases.

Gastric adenoma is unquestionably a precancerous lesion that accounts for 5% to 10% of gastric polyps, and the cancer potential increases with the degree of histological dysplasia. A reported 11% of gastric adenomas progress to gastric cancer within 4 years of follow-up. Therefore, even in adenoma, thorough endoscopic checks and histological examinations in the presence or absence of a cancerous lesion.

ENDOSCOPIC EXAMINATION WITHOUT BLIND SPOTS

A recent analysis of the endoscopic miss rate of 103 patients with EGC and high-grade dysplasia revealed that the miss rate of lesions in the esophagogastric junction area was statistically high (p=0.022), while lesions in the upper gastric area were relatively more frequently missed than those in the lower gastric and antral areas.11 It is well known that the blind spots of upper gastric endoscopy are the cardia, greater curvature of the upper part, posterior area of the body, pyloric area, and lesser curvature of the antrum (Fig. 1).

Since a specific area of the cardia is covered by the scope itself during endoscopy, it should be inspected from different angles by rotation of the scope and the use of U-turns and J-turns. Additionally, the fundus can be checked using retroversion of the scope on the cardia as well as by inferior migration and careful observation of the lesser curvature and posterior wall. In particular, since the posterior wall of the great curvature is usually not fully exposed, concomitant aeration and suction should be performed to ensure clear visibility. During scope removal, the body and posterior wall of the cardia should be checked again along with the anterior wall of the greater curvature and the fundus.

The great curvature of the body is clearly observable after the removal of retained gastric fluid and aeration. When observing this area, one should pay attention to whether the fold and thickness of the great curvature are well expanded after aeration and whether there are any changes in color or differences in fold shape or thickness. Any gastric fold running differently to the adjacent folds indicates an ulcerative lesion at the end of the fold that should be carefully inspected.

The lesser curvature of the antrum, a well-known blind spot, can be seen by scope retraction with the tip directed upward and observation in near and far views by repeating the same procedure of moving upward and downward and changing the perspective.

The posterior part of the proximal antrum is another area that can be missed. During the observation of this area from one angle, the tip of the scope should be twisted to the right to reveal the mucosal layer shape. The area can again be seen during scope removal after straightening. An endoscopist should always try to remove all mucus attached to the mucosa by using adequate aeration and suction and should observe the lesion closely.

Serial steps of examination and filming are also recommended to ensure that blind spots are not missed during endoscopic examination. Indeed, the European Society of Gastrointestinal Endoscopy announced a standardized filming recommendation to enhance endoscopy quality.12 Furthermore, Yao13 recently reported the use of 22 basic endoscopic films of each area to ensure an endoscopy that is free of blind spots.

ENDOSCOPIC FINDINGS OF EGC

The newest endoscopic technologies of magnification endoscopy and narrow band imaging (NBI) endoscopy, which comprise image-enhanced endoscopy, are very helpful for characterizing gastrointestinal lesions; however, white light endoscopy remains the core endoscopic technology for detecting EGC.14 EGC has various morphologies, from subtle mucosal surface changes to color changes (Fig. 2). According to recently reported endoscopic findings in Korea, of 1,942 patients, 306 (16.6%) were diagnosed with elevated-type EGC, 528 (28.6%) with flat-type EGC, and 1,011 (54.8%) with depressed-type EGC. Intestinal-type EGC and well/moderately differentiated lesions were macroscopically observed as elevated-type EGC, while signet ring cells and poorly differentiated lesions were observed as relatively flat and depressed types (p<0.001).15 Protruded (0-I) and excavated (0-III) types are fairly easily diagnosed by endoscopic examination, whereas superficial (0-II) types are not since some superficial types of cancer resemble gastritis.16

Superficial depressed lesions (0-IIc)

Depressed lesions, such as erosions and ulcers, show a variety of types ranging from those that are definite to those that are not. Deep depressions, those accompanied by definite elevations, and clear-colored lesions are easily observed. A characteristically depressed lesion can be accompanied by converging folds, which can show abrupt cutting, clubbing, fusion, or a rat-tail appearance (Figs. 3, 4).

However, shallow depressions can easily be overlooked. Therefore, the need arises to adjust the endoscope angle and direction as well as the distance, air supply, and air intake. If concave/convex changes or color differences, blood vessel projections, or gloss differences in the surface and mucosa are observed on endoscopy, a closer observation should be performed using chromoendoscopy with indigo carmine spray or endoscopy for image enhancement. When a shallow or local depression that differs from the surrounding normal mucosa is seen, it is important to determine whether the lesion is normal or malignant. Accordingly, a biopsy should be conducted to evaluate the color differences compared to the surrounding normal mucosa and observe whether the boundary, shape, and color of the depressed surface is worm-eaten or has been encroached upon.

Superficial flat lesions (0-IIb)

Type IIb lesions are nearly flat and have redness and sometimes, a whitish discoloration (Fig. 5). Compared with the surrounding normal mucosa, an irregular vascular bed or disappearance without a color change is observed. The permeable vascular bed can be irregularly discolored in places. Excessive aeration could make it difficult to recognize pathological lesions; therefore, if an endoscopist finds an abnormal site, he or she should repeatedly use aeration and suction in an effort not to miss the pathological lesions. Differentiated type IIb lesions generally look red because a tumor can have proliferated capillaries in the submucosal layer and a continuously clear boundary. In contrast, undifferentiated type tumors intermittently infiltrate the normal gastric glands through the mucosa's middle to deep layers. Therefore, because these tumors retain a normal, noncancerous epithelium, a whitish discoloration on the surface is frequently observed. There are many cases of uncertain boundaries and no capillary proliferation in the lamina propria mucosae.17

Superficial elevated lesions (0-IIa)

Type I EGC is relatively easy to find during endoscopic examinations. This type appears as a sessile or semi-pedunculated mucosal mass that is bigger than a benign polyp. This is occasionally accompanied by bleeding and shows a granular or lobular appearance with mucosal changes, erosion, or depressions. Compared to type I, type IIa is slightly more elevated than the adjacent mucosa. This type shows an irregular surface as well as redness or paleness. These lesions can be limited to the mucosa without significant mucosal fold changes. If there are significant mucosal fold changes or central dimpling, submucosal infiltration is highly probable.

CHROMOENDOSCOPIC EXAMINATION

Chromoendoscopy using indigo carmine, the most commonly used staining agent, is helpful for clarifying endoscopic findings that are ambiguous on conventional endoscopy. Its use also helps discern small erosive lesions that are only depressed in the center but have no surrounding mucosal elevation. However, issues arise with chromoendoscopy when staining dyes are used and subsequently unclear endoscopic findings are noted. These issues include the inconveniences of applying staining agents, uneven spreading, and lesion stagnation. Chemical staining methods using methylene blue and acetic acid have reportedly helped with the diagnosis of some cases of EGC. Lee et al.18 recently reported that serial application of acetic acid and indigo carmine is helpful for diagnosing EGC and clarifying marginal locations. Nevertheless, the chemical staining method is not universally used in actual clinical practice compared to the indigo carmine method.

The introduction of various advanced image-enhanced endoscopic technologies such as magnifying endoscopy and NBI in recent years compensates for the aforementioned weaknesses of the indigo carmine and chemical staining methods. However, the stomach cavity is wide, and its subepithelial capillary network is well developed compared to that of the esophagus. Therefore, it is difficult to observe lesions using NBI since they appear to dark and grainy on the subsequent images. To observe the overall gastric area and diagnose any lesions, experts recommend first using white light endoscopy to locate any suspected lesions and then use NBI for further evaluation. This enables the observation of the microvascular (MV) patterns and microsurface (MS) structures of suspected lesions during the diagnostic process.19 Experienced endoscopists in the Asia-Pacific region generally feel that NBI is not useful for detecting EGC and recommend that endoscopists be trained in conventional endoscopy or chromoendoscopy to detect EGC.20 In real clinical practice, advanced magnifying and image-enhanced endoscopes are much more helpful in the analysis of lesions, targeting of biopsies, and determination of marginal locations for endoscopic resection since they enable visualizing of the unevenness and existence of MV patterns and MS structures.21

CONCLUSIONS

Although endoscopy is a well-developed and advanced technique, the responsibility of performing endoscopy well and making an accurate diagnosis remains with the endoscopist. For these reasons, endoscopists should take a patient's past history before the procedure to predict their risk of gastric cancer and examine the patient conscientiously with a modest attitude. Furthermore, when an operator encounters a lesion that has some features of malignancy, he or she should record this in detail and perform an endoscopic biopsy. Finally, the endoscopist must provide the patient with a comprehensive consultation after the procedure as well as follow-up whenever indicated.

Conflicts of Interest: The author has no financial conflicts of interest.

REFERENCES

1. National Cancer Information Center. The incidence [Internet]. Goyang: National Cancer Information Center; c2012. cited 2015 Jun 10]. Available from: http://cancer.go.kr.
2. Hosokawa O, Miyanaga T, Kaizaki Y, et al. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand J Gastroenterol 2008;43:1112–1115. 18609154.Article PubMed
3. Nam SY, Choi IJ, Park KW, et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol 2009;21:855–860. 19369882.Article PubMed
4. Chadwick G, Groene O, Riley S, et al. Gastric cancers missed during endoscopy in England. Clin Gastroenterol Hepatol 2015 1 30 [Epub]. 10.1016/j.cgh.2015.01.025.Article
5. Lee HL, Eun CS, Lee OY, et al. When do we miss synchronous gastric neoplasms with endoscopy? Gastrointest Endosc 2010;71:1159–1165. 20381041.Article PubMed
6. Cho YS, Chung IK, Kim JH, et al. Risk factors of developing interval early gastric cancer after negative endoscopy. Dig Dis Sci 2015;60:936–943. 25316551.Article PubMed
7. Zanghieri G, Di Gregorio C, Sacchetti C, et al. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 1990;66:2047–2051. 2224804.Article PubMed
8. Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol 2012;18:1279–1285. 22493541.Article PubMed PMC
9. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945–952. 18395075.Article PubMed
10. Bang BW, Kim HG. Endoscopic classification of intestinal metaplasia. Korean J Helicobacter Up Gastrointest Res 2013;13:78–83.Article
11. Ren W, Yu J, Zhang ZM, Song YK, Li YH, Wang L. Missed diagnosis of early gastric cancer or high-grade intraepithelial neoplasia. World J Gastroenterol 2013;19:2092–2096. 23599630.Article PubMed PMC
12. Rey JF, Lambert R. ESGE Quality Assurance Committee. ESGE recommendations for quality control in gastrointestinal endoscopy: guidelines for image documentation in upper and lower GI endoscopy. Endoscopy 2001;33:901–903. 11605605.Article PubMed PDF
13. Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol 2013;26:11–22. 24714327.PubMed PMC
14. Otsuka Y, Niwa Y, Ohmiya N, et al. Usefulness of magnifying endoscopy in the diagnosis of early gastric cancer. Endoscopy 2004;36:165–169. 14765314.Article PubMed PDF
15. Jung da H, Park YM, Kim JH, et al. Clinical implication of endoscopic gross appearance in early gastric cancer: revisited. Surg Endosc 2013;27:3690–3695. 23588711.Article PubMed
16. Teh JL, Hartman M, Lau L, et al. Duration of endoscopic examination significantly impacts detection rates of neoplastic lesions during diagnostic upper endoscopy. Gastrointest Endosc 2011;73(4 Suppl):AB393.Article
17. Lee JH. EGC IIb and minute gastric cancer. Korean J Gastrointest Endosc 2011;43(Suppl 2):218–219.
18. Lee BE, Kim GH, Park do Y, et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type. BMC Gastroenterol 2010;10:97. 20731830.Article PubMed PMC PDF
19. Yao K, Nagahama T, Matsui T, Iwashita A. Detection and characterization of early gastric cancer for curative endoscopic submucosal dissection. Dig Endosc 2013;25(Suppl 1):44–54. 23362939.Article PubMed
20. Uedo N, Fujishiro M, Goda K, et al. Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: current consensus of experienced endoscopists in Asia-Pacific region. Dig Endosc 2011;23(Suppl 1):58–71. 21535204.Article PubMed
21. Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 2009;41:462–467. 19418401.Article PubMed PDF

Fig. 1

Endoscopic findings of various early gastric cancer (EGC) lesions in the blind spot areas. (A) A flat erythematous lesion (EGC 0-IIb) at the cardia. (B) An irregular flat lesion (EGC 0-IIb) in the posterior wall of the upper body. (C) A disrupted mucosal fold (EGC 0-IIc) in the greater curvature of the upper body. (D) A discolored flat lesion (EGC 0-IIb) in the posterior wall of the lower body. (E) A reddish flat lesion (EGC 0-IIb) in the P-ring. (F) A well-demarcated depressed lesion (EGC 0-IIc) in the lesser curvature of the antrum.

Fig. 2

Endoscopic findings of early gastric cancer (EGC) lesions. (A) A whitish, elevated flat lesion (EGC 0-IIa) shown at an angle. (B) A doughnut-like elevated lesion (EGC 0-IIc) in the lesser curvature of the lower body. (C) A reddish depression (EGC 0-IIc) in the lesser curvature of the antrum. (D) Reddish mucosal changes (EGC 0-IIb) in the angle. (E) Whitish mucosa changes (EGC 0-IIb) in the angle. (F) Granular mucosal changes (EGC 0-IIb) in the greater curvature of the lower body.

Fig. 3

Endoscopic finding of the depressed lesion type in early gastric cancer.

Fig. 4

Endoscopic findings. (A) A mucosal convergence is noted, but no elevation at the tip of the converging folds is seen, and the depth of invasion is thus diagnosed as limited to the mucosa. (B) Remarkable elevation of the tumor is seen with a converging fold. These findings fulfill the criteria for massive submucosal invasion by cancer.

Fig. 5

Endoscopic finding of the flat lesion type in early gastric cancer (A, B).

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Preoperative diagnosis of tumor depth in gastric cancer using transabdominal ultrasonography compared to using endoscopy and computed tomography
Shinya Urakawa, Toshiya Michiura, Shinji Tokuyama, Yasunari Fukuda, Yasuaki Miyazaki, Nobuyasu Hayashi, Kazuo Yamabe
Surgical Endoscopy.2023; 37(5): 3807. CrossRef
Clinical and endoscopic features of metachronous gastric cancer with possible lymph node metastasis after endoscopic submucosal dissection and Helicobacter pylori eradication
Haruhisa Suzuki, Satoru Nonaka, Iruru Maetani, Takahisa Matsuda, Seiichiro Abe, Shigetaka Yoshinaga, Ichiro Oda, Yukinori Yamagata, Takaki Yoshikawa, Yutaka Saito
Gastric Cancer.2023; 26(5): 743. CrossRef
Identification of gaze pattern and blind spots by upper gastrointestinal endoscopy using an eye-tracking technique
Ayoung Lee, Hyunsoo Chung, Yejin Cho, Jue Lie Kim, Jinju Choi, Eunwoo Lee, Bokyung Kim, Soo-Jeong Cho, Sang Gyun Kim
Surgical Endoscopy.2022; 36(4): 2574. CrossRef
Endoscopic diagnosis of early gastric cancer
Dong Chan Joo, Gwang Ha Kim
Journal of the Korean Medical Association.2022; 65(5): 267. CrossRef
Risk factors for early gastric cancer: focus on Helicobacter pylori gastritis
Hee Seok Moon
Journal of the Korean Medical Association.2022; 65(5): 259. CrossRef
Redundant Electromagnetic Control of an Endoscopic Magnetic Capsule Driven by Multiple Electromagnets Configuration
Jayoung Kim, Han-Sol Lee, Manh Cuong Hoang, Seonghwan Jeong, Jae-Seung Kim, Cheong Lee, Byungjeon Kang, Jonghee Lee, Young-Don Son, Seungmin Bang, Eunpyo Choi, Jong-Oh Park, Chang-Sei Kim
IEEE Transactions on Industrial Electronics.2022; 69(11): 11370. CrossRef
Intelligent detection endoscopic assistant: An artificial intelligence-based system for monitoring blind spots during esophagogastroduodenoscopy in real-time
Yan-Dong Li, Shu-Wen Zhu, Jiang-Ping Yu, Rong-Wei Ruan, Zhao Cui, Yi-Ting Li, Mei-Chao Lv, Huo-Gen Wang, Ming Chen, Chao-Hui Jin, Shi Wang
Digestive and Liver Disease.2021; 53(2): 216. CrossRef
A comparative time‐dependent study of hematology, serum gastrin concentrations, and gastroscopic assessment of meloxicam‐induced gastric ulceration in dogs
Ahmed Elfadadny, Ahmed S. Mandour, Rokaia F. Ragab, Khalaf F. Alsharif, Gaber El‐Saber Batiha, Haney Samir, Noha A. Beder
Journal of Veterinary Internal Medicine.2021; 35(5): 2196. CrossRef
Comparing blind spots of unsedated ultrafine, sedated, and unsedated conventional gastroscopy with and without artificial intelligence: a prospective, single-blind, 3-parallel-group, randomized, single-center trial
Di Chen, Lianlian Wu, Yanxia Li, Jun Zhang, Jun Liu, Li Huang, Xiaoda Jiang, Xu Huang, Ganggang Mu, Shan Hu, Xiao Hu, Dexin Gong, Xinqi He, Honggang Yu
Gastrointestinal Endoscopy.2020; 91(2): 332. CrossRef
Đánh giá kết quả chẩn đoán và điều trị ung thư dạ dày sớm tại Bệnh viện Trung ương Huế
Nhật Tân Phan
Journal of Clinical Medicine- Hue Central Hospital.2020;[Epub] CrossRef
Taking More Gastroscopy Images Increases the Detection Rate of Clinically Significant Gastric Lesions: Validation of a Systematic Screening Protocol for the Stomach
Ja In Lee, Joon Sung Kim, Byung-Wook Kim, Cheal Wung Huh
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(3): 225. CrossRef
TriZ-a rotation-tolerant image feature and its application in endoscope-based disease diagnosis
Ruixue Zhao, Ruochi Zhang, Tongyu Tang, Xin Feng, Jialiang Li, Yue Liu, Renxiang Zhu, Guangze Wang, Kangning Li, Wenyang Zhou, Yunfei Yang, Yuzhao Wang, Yuanjie Ba, Jiaojiao Zhang, Yang Liu, Fengfeng Zhou
Computers in Biology and Medicine.2018; 99: 182. CrossRef
Linked colour imaging benefits the endoscopic diagnosis of distal gastric diseases
Xiaotian Sun, Yiliang Bi, Tenghui Dong, Min Min, Wei Shen, Yang Xu, Yan Liu
Scientific Reports.2017;[Epub] CrossRef
High-Risk Gastric Pathology and Prevalent Autoimmune Diseases in Patients with Pernicious Anemia
Jing W. Hughes, Brian D. Muegge, Garry S. Tobin, Marina Litvin, Lulu Sun, Jose B. Saenz, C. Prakash Gyawali, Janet B. McGill
Endocrine Practice.2017; 23(11): 1297. CrossRef
Long-term clinical outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for early gastric cancer
Wei Lu, Jian Gao, Jingyun Yang, Yijian Zhang, Wenjie Lv, Jiasheng Mu, Ping Dong, Yingbin Liu
Medicine.2016; 95(27): e3986. CrossRef
Highlights from the 52nd Seminar of the Korean Society of Gastrointestinal Endoscopy
Eun Young Kim, Il Ju Choi, Kwang An Kwon, Ji Kon Ryu, Ki Baik Hahm
Clinical Endoscopy.2015; 48(4): 269. CrossRef
Detection of gastric cancer using transabdominal ultrasonography is associated with tumor diameter and depth of invasion
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, KAZUNORI FUGO, RUMIKO HASEGAWA, YOSHINORI SHIRAI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, TAKASHI KISHIMOTO, NAOKI ISHIGE
Experimental and Therapeutic Medicine.2015; 10(5): 1835. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Improving the Endoscopic Detection Rate in Patients with Early Gastric Cancer

Clin Endosc. 2015;48(4):291-296. Published online July 24, 2015

DOI: https://doi.org/10.5946/ce.2015.48.4.291

XML Download

Figure

Related articles

Improving the Endoscopic Detection Rate in Patients with Early Gastric Cancer

Fig. 1 Endoscopic findings of various early gastric cancer (EGC) lesions in the blind spot areas. (A) A flat erythematous lesion (EGC 0-IIb) at the cardia. (B) An irregular flat lesion (EGC 0-IIb) in the posterior wall of the upper body. (C) A disrupted mucosal fold (EGC 0-IIc) in the greater curvature of the upper body. (D) A discolored flat lesion (EGC 0-IIb) in the posterior wall of the lower body. (E) A reddish flat lesion (EGC 0-IIb) in the P-ring. (F) A well-demarcated depressed lesion (EGC 0-IIc) in the lesser curvature of the antrum.

Fig. 2 Endoscopic findings of early gastric cancer (EGC) lesions. (A) A whitish, elevated flat lesion (EGC 0-IIa) shown at an angle. (B) A doughnut-like elevated lesion (EGC 0-IIc) in the lesser curvature of the lower body. (C) A reddish depression (EGC 0-IIc) in the lesser curvature of the antrum. (D) Reddish mucosal changes (EGC 0-IIb) in the angle. (E) Whitish mucosa changes (EGC 0-IIb) in the angle. (F) Granular mucosal changes (EGC 0-IIb) in the greater curvature of the lower body.

Fig. 3 Endoscopic finding of the depressed lesion type in early gastric cancer.

Fig. 4 Endoscopic findings. (A) A mucosal convergence is noted, but no elevation at the tip of the converging folds is seen, and the depth of invasion is thus diagnosed as limited to the mucosa. (B) Remarkable elevation of the tumor is seen with a converging fold. These findings fulfill the criteria for massive submucosal invasion by cancer.

Fig. 5 Endoscopic finding of the flat lesion type in early gastric cancer (A, B).